September 13: Biosimilars: Issues, Challenges, and Strategy for Success

A popular misbelief prevails in the United States that our healthcare system is the best and most efficient in the world. The facts, however, state otherwise. According to multiple reports, including a 2013 Institute of Medicine report, the US healthcare system ranks at the bottom of most developed economies while simultaneously being the most expensive.1 The primary reason for this discord in efficiency is a lack of competition in the healthcare markets coupled with a lack of agility.

Read the full article on The Center for Biosimilars here.

2017-09-13T08:56:03+00:00